会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 34. 发明授权
    • Benzazolythio-carbapenem antibiotics
    • 苯扎硫代碳青霉烯类抗生素
    • US4840946A
    • 1989-06-20
    • US119752
    • 1987-11-12
    • Dieter HabichWolfgang HartwigKarl G. MetzgerHans-Joachim Zeiler
    • Dieter HabichWolfgang HartwigKarl G. MetzgerHans-Joachim Zeiler
    • C07D477/00A61K31/397A61K31/41A61P31/04C07D477/20
    • C07D477/20Y02P20/55
    • Antibiotically active benzazolylthio-carbapenems of the formula ##STR1## in which R.sup.1 represents hydrogen or a hydroxyl-protecting group,R.sup.2 represents hydrogen or a carboxyl-protecting group or an ester radical which can be cleaved off in vivo,R.sup.3 represents hydrogen or C.sub.1 -C.sub.10 -alkyl, C.sub.6 -C.sub.12 -aryl or C.sub.7 -C.sub.14 -aralkyl,R.sup.4 represents hydrogen or represents C.sub.1 -C.sub.10 -alkyl, C.sub.6 -C.sub.12 -aryl or C.sub.7 -C.sub.14 aralkyl, or represents C.sub.1 -C.sub.10 -alkylsulphonyl, C.sub.6 -C.sub.12 -arylsulphonyl or C.sub.7 -C.sub.14 -aralkylsulphonyl, or represents an amino-protecting group, or represents a group of the formula ##STR2## in which R.sup.5, R.sup.6 and R.sup.8 are indentical or different and denote hydrogen, C.sub.1 -C.sub.10 -alkyl, C.sub.6 -C.sub.12 -aryl or C.sub.7 -C.sub.14 -aralkyl,andX represents O, S, NH or NCH.sub.3,or salts thereof.
    • 其中R 1表示氢或羟基保护基,R 2表示氢或羧基保护基或可在体内被切割的酯基的式为“IMAGE”的抗生素活性苯并唑基硫代碳青霉烯类,R3表示氢或C1- C 1 -C 12 - 芳基或C 7 -C 14 - 芳烷基,R 4表示氢或C 1 -C 10 - 烷基,C 6 -C 12 - 芳基或C 7 -C 14芳烷基,或表示C 1 -C 10 - 烷基磺酰基,C 6 -C 12 - 或芳基磺酰基或C 7 -C 14 - 芳烷基磺酰基,或表示氨基保护基,或表示其中R 5,R 6和R 8表示氢,C 1 -C 10 - 烷基,C 6 -C 12 芳基或C 7 -C 14 - 芳烷基,X表示O,S,NH或NCH 3或其盐。
    • 38. 发明授权
    • Novel .beta.-lactam antibiotics
    • 新型β-内酰胺抗生素
    • US4632918A
    • 1986-12-30
    • US730979
    • 1985-05-06
    • Rolf AngerbauerMichael BobergKarl G. MetzgerHans-Joachim Zeiler
    • Rolf AngerbauerMichael BobergKarl G. MetzgerHans-Joachim Zeiler
    • A23K20060101A23K1/17A23K3/02A61K20060101A61K31/545A61K31/546A61P31/04C07D20060101C07D277/40C07D417/12C07D417/14C07D501/16C07D501/18C07D501/24C07D501/38C07D501/46C07D501/56C09K20060101C09K15/30
    • C07D501/46C07D501/18
    • Novel .beta.-lactam antibiotics of the formula ##STR1## in which R.sup.1, R.sup.2 and R.sup.3, which may be identical or different, denote a substituted or unsubstituted alkyl radical or a monocyclic or bicyclic, optionally substituted, carbocyclic or heterocyclic ring, orR.sup.1 represents an optionally substituted alkyl radical or a monocyclic or bicyclic, substituted or unsubstituted, carbocyclic or heterocyclic ring, andR.sup.2 and R.sup.3, together with the N.sup..sym. atom, form an optionally substituted monocyclic or polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, orR.sup.1, R.sup.2 and R.sup.3, together with the N.sup..sym. atom, form a bridged, optionally substituted polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, andR.sup.4 represents hydrogen or optionally substituted alkyl, aryl or heterocyclyl or hydroxycarbonyl, lower alkoxycarbonyl, halogen, pseudohalogen or a group of the formula ##STR2## in which n denotes 0, 1 or 2, andB represents a direct bond, oxygen or a group ##STR3## and A and W, independently of one another, represent hydrogen or optionally substituted alkyl, aryl or heterocyclyl, or together form an optionally substituted carbocyclic or heterocyclic ring.
    • 新颖的具有式“IMAGE”的β-内酰胺抗生素,其中R1,R2和R3可以相同或不同,表示取代或未取代的烷基或单环或双环,任选取代的碳环或杂环,或R 1表示 任选取代的烷基或单环或双环,取代或未取代的碳环或杂环,并且R 2和R 3与N(+)原子一起形成可以是饱和或不饱和的任选取代的单环或多环, 含有氧,硫和氮作为其它杂原子,或者R 1,R 2和R 3与N(+)原子一起形成可以是饱和或不饱和的并且可以含有氧,硫和氮的桥连的任选取代的多环, 其它杂原子,R 4表示氢或任选取代的烷基,芳基或杂环基或羟基羰基,低级烷氧基羰基,卤素,假卤素或式IMAG E>其中n表示0,1或2,B表示直接键,氧或基团,且A和W彼此独立地表示氢或任选取代的烷基,芳基或杂环基,或一起形成 任选取代的碳环或杂环。